Pulmonary hypertension: Difference between revisions
Jump to navigation
Jump to search
imported>Meg Taylor (subpages) |
imported>Robert Badgett (Started treatment section) |
||
| Line 4: | Line 4: | ||
==Diagnosis== | ==Diagnosis== | ||
The [[echocardiogram]] may be more than 10 mm/Hg in error in half of cases.<ref name="pmid19164700">{{cite journal |author=Fisher MR, Forfia PR, Chamera E, ''et al'' |title=Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension |journal=Am. J. Respir. Crit. Care Med. |volume=179 |issue=7 |pages=615–21 |year=2009 |month=April |pmid=19164700 |doi=10.1164/rccm.200811-1691OC |url=http://ajrccm.atsjournals.org/cgi/pmidlookup?view=long&pmid=19164700 |issn=}}</ref> | The [[echocardiogram]] may be more than 10 mm/Hg in error in half of cases.<ref name="pmid19164700">{{cite journal |author=Fisher MR, Forfia PR, Chamera E, ''et al'' |title=Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension |journal=Am. J. Respir. Crit. Care Med. |volume=179 |issue=7 |pages=615–21 |year=2009 |month=April |pmid=19164700 |doi=10.1164/rccm.200811-1691OC |url=http://ajrccm.atsjournals.org/cgi/pmidlookup?view=long&pmid=19164700 |issn=}}</ref> | ||
==Treatment== | |||
For all patients, consider: | |||
* Inhibitors of [[phosphodiesterase]] type 5 (PDE-5), such as [[sildenafil]]. | |||
For patients with New York Heart Association (NYHA) class IV symptoms inspite of calcium-channel antagonists, consider: | |||
* [[Prostaglandin]]s, such as [[iloprost]], [[treprostinil]], or [[epoprostenol]]. | |||
* [[Endothelin]] receptor antagonists such as [[bosentan]]. | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 09:45, 19 March 2010
In medicine, pulmonary hypertension is "increased vascular resistance in the pulmonary circulation, usually secondary to heart diseases or lung diseases."[1]
Diagnosis
The echocardiogram may be more than 10 mm/Hg in error in half of cases.[2]
Treatment
For all patients, consider:
- Inhibitors of phosphodiesterase type 5 (PDE-5), such as sildenafil.
For patients with New York Heart Association (NYHA) class IV symptoms inspite of calcium-channel antagonists, consider:
- Prostaglandins, such as iloprost, treprostinil, or epoprostenol.
- Endothelin receptor antagonists such as bosentan.
References
- ↑ Anonymous (2024), Pulmonary hypertension (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Fisher MR, Forfia PR, Chamera E, et al (April 2009). "Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension". Am. J. Respir. Crit. Care Med. 179 (7): 615–21. DOI:10.1164/rccm.200811-1691OC. PMID 19164700. Research Blogging.